The Global Ophthalmology Awards Program demonstrates Bayer's commitment to the ophthalmology community and to advancing state-of-the-art ophthalmic care. As award decisions are taken by the independent Grants Review and Awards Committee, and are based on an applicant’s merit and eligibility, all decisions are final and not subject to appeal.
The Research Award is designed to support a wide range of research projects (basic and clinical) in the field of retinal ophthalmology, including diagnosis and assessment, treatment, surgery, quality of life, and mechanisms of action.
Applicants must have an MD or PhD and be affiliated with a facility that carries out research in ophthalmology, including medical schools, universities, hospitals, treatment centers, and laboratories.
Applicants will be judged according to the following criteria:
- Scientific merit of hypotheses and experimental approach
- Innovation in design, methodology and objectives
- Impact on future clinical or scientific understanding of retinal disorders
- Quality of research environment
- Alignment with program mission and objectives
Research Awards will provide funding of up to US$50,000 per award for 1 year in the majority of cases. Additional funding will be considered, but must be justified.
Payment must be made to the awardee’s institution rather than directly to the awardee. The grant will be paid in three installments, and receipt of satisfactory interim progress and financial reports is necessary before payment of the second and third installments are made.